+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Perfluorocarbon-based Ultrasound Contrast Agents Market by Application (Cardiology, Oncology, Radiology), Technology Type (Liquids, Microbubbles, Nanobubbles), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Perfluorocarbon-based Ultrasound Contrast Agents Market by Application (Cardiology, Oncology, Radiology), Technology Type (Liquids, Microbubbles, Nanobubbles), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
New

Perfluorocarbon-based Ultrasound Contrast Agents Market by Application (Cardiology, Oncology, Radiology), Technology Type (Liquids, Microbubbles, Nanobubbles), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145740
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Perfluorocarbon-based ultrasound contrast agents have emerged as pivotal tools in modern medical imaging, offering unparalleled contrast enhancement and diagnostic accuracy. Unlike traditional agents, these formulations leverage the physicochemical properties of perfluorocarbons to achieve superior echogenicity, stability, and biocompatibility. Over the past decade, research advancements have focused on optimizing bubble size, shell composition, and gas solubility to extend circulation time and target specific tissues. Clinical adoption has accelerated in cardiology, oncology, and radiology as practitioners seek more reliable visualization of perfusion dynamics and lesion characterization. However, navigating regulatory landscapes and ensuring consistent manufacturing quality remain critical considerations for both established producers and new entrants. This section lays the groundwork for understanding the fundamental advantages that perfluorocarbon agents bring to ultrasound diagnostics, while also acknowledging the scientific, regulatory, and commercial factors that shape ongoing innovation.

Unveiling the Pivotal Technological Regulatory and Market Drivers Reshaping the Ultrasound Contrast Agent Environment with Perfluorocarbon Innovations

The landscape of ultrasound contrast has undergone transformative shifts driven by converging technological breakthroughs and evolving regulatory frameworks. Recent years have witnessed a migration from conventional air-filled bubbles to perfluorocarbon gas cores engineered for extended stability and enhanced acoustic reflectivity. Concurrently, advancements in microbubble shell materials-ranging from lipid to polymer to protein coatings-have unlocked new opportunities in targeted imaging and theranostics. Regulators worldwide have become more receptive to novel formulations, expediting approval pathways for agents that demonstrate clear clinical benefits. Meanwhile, the integration of artificial intelligence and machine learning into image analysis platforms has allowed radiologists to extract quantitative perfusion metrics with unprecedented precision. These paradigm shifts are redefining how clinicians approach diagnostic workflows, paving the way for more personalized imaging protocols and data-driven decision making in real time.

Assessing the Comprehensive Effects of the 2025 United States Tariff Measures on Supply Chains Production Costs and Market Dynamics

In 2025, the United States implemented a series of tariffs on perfluorocarbon raw materials and intermediate compounds, leading to a multifaceted impact on production costs and supply chain configurations. Manufacturers responded by seeking alternative sourcing arrangements, including onshoring key processes and diversifying supplier bases beyond traditional markets. As a result, negotiated contract terms shifted to incorporate cost-pass-through provisions, and strategic alliances emerged to secure stable inputs for high-purity fluorochemicals. Across the value chain, logistics providers adapted to new trade routes, while research institutions explored domestically sourced substitutes to mitigate exposure to import duties. Despite initial cost inflation, these adjustments have fostered greater resilience, prompting stakeholders to reassess inventory strategies and prioritize local manufacturing capabilities for long-term supply assurance.

Deriving Actionable Perspectives from Application Technology End User and Distribution Channel Segmentations Informing Market Development Strategies

Comprehensive segmentation of the ultrasound contrast agent market reveals nuanced insights that guide strategic positioning. In clinical applications, cardiology stakeholders emphasize left ventricular function analysis and myocardial perfusion imaging, while oncology practices leverage contrast dynamics for lesion detection and tumor characterization, and radiology teams exploit enhanced visualization in abdominal, pediatric, and vascular contexts. The technology dimension spans liquid formulations of decafluorobutane and perfluorooctyl bromide, microbubbles featuring lipid, polymer, or protein shells, and nanobubbles engineered with lipid or protein coatings to infiltrate microvasculature. End users range from outpatient and specialty clinics to diagnostic centers encompassing cardiac care and imaging facilities, as well as hospitals and research institutes that include academic entities and contract research organizations. Distribution channels vary from direct engagement through group purchasing organizations and hospital partnerships to intermediary sales via national and regional distributors, alongside digital commerce through manufacturer websites and third-party platforms. Integrating these layers of segmentation illuminates demand drivers, adoption barriers, and channel dynamics that inform optimized commercialization strategies.

Analyzing Regional Performance Patterns and Growth Trajectories across the Americas Europe Middle East Africa and Asia Pacific for Ultrasound Contrast Markets

Regional market dynamics underscore distinct growth patterns shaped by economic, regulatory, and healthcare infrastructure factors. In the Americas, mature reimbursement frameworks and established clinical protocols support widespread adoption of advanced contrast agents, while North American centers of excellence accelerate translational research in perfusion imaging. Europe, the Middle East and Africa present a heterogeneous landscape in which regulatory harmonization across the EU coexists with emerging opportunities in the Gulf Cooperation Council and sub-Saharan African markets that are building capacity for advanced diagnostics. Across Asia Pacific, expanding healthcare infrastructure, increasing prevalence of chronic cardiovascular and oncological conditions, and growing government investment in diagnostic modernization fuel rapid uptake. Yet each subregion exhibits unique payer systems and regulatory requirements, necessitating tailored market entry approaches and localized partnership models to capture healthcare providers’ interest.

Highlighting Strategic Movements Innovations Collaborations and Competitive Positioning of Leading Corporations in the Perfluorocarbon Ultrasound Contrast Sector

Leading corporations have pursued differentiated strategies to maintain competitive advantage in the perfluorocarbon ultrasound contrast arena. Established imaging companies have emphasized portfolio diversification through incremental enhancements in bubble formulation and acoustic performance. Strategic collaborations between specialty chemical manufacturers and molecular imaging developers have accelerated the translation of novel gas cores and shell materials into clinical trials. Concurrently, mid-tier players and niche innovators have focused on proprietary nanobubble technologies to enable molecular targeting and drug delivery functionalities. Across the spectrum, mergers and acquisitions remain prevalent as organizations seek to consolidate research capabilities, expand geographic reach, and integrate complementary imaging modalities. These competitive maneuvers reflect a broader industry drive toward end-to-end solutions encompassing contrast agent performance, imaging platform compatibility, and data analytics integration.

Recommending Tailored Strategic Initiatives for Manufacturers Regulators and Stakeholders to Strengthen Market Position and Accelerate Growth Opportunities

To capitalize on emerging market opportunities, industry leaders should prioritize collaborative R&D initiatives that refine perfluorocarbon formulations for optimized circulation half-life and targeted delivery. Engaging with regulatory bodies early in the development cycle can expedite approval timelines and ensure alignment with evolving safety guidelines. Strengthening partnerships with imaging equipment manufacturers and AI developers will enhance compatibility and drive value-added service offerings. Organizations must also invest in supply chain resilience by diversifying raw material sources, implementing predictive inventory models, and exploring localized manufacturing hubs. Fostering end user education through specialized training initiatives will accelerate clinical adoption and facilitate reimbursement negotiations. Finally, leveraging digital engagement platforms can broaden access within underserved markets and support real-time data capture for post-market surveillance and continuous performance improvement.

Describing the Rigorous Multi Source Research Framework Employed to Generate Reliable Insights into Perfluorocarbon Ultrasound Contrast Market Dynamics

The research framework underpinning this analysis integrates primary and secondary data sources to ensure robust and validated insights. Primary research included in-depth interviews with senior executives, R&D directors, and clinical key opinion leaders across major regions, supplemented by carefully structured questionnaires. Secondary research encompassed a comprehensive review of regulatory filings, peer-reviewed scientific publications, patent databases, and industry white papers. Quantitative data extraction and trend analysis were performed using proprietary databases, with findings subjected to cross validation through triangulation methodologies. Quality assurance measures involved iterative reviews by domain experts and validation workshops with external stakeholders. This rigorous multi-source approach provides a transparent and reproducible basis for the strategic observations and recommendations presented herein.

Synthesizing Key Insights and Industry Observations to Formulate a Coherent Summary of Market Progress Challenges and Future Prospects

In synthesizing the key observations, it is evident that perfluorocarbon-based ultrasound contrast agents are poised to redefine diagnostic imaging through enhanced stability, targeted capabilities, and integration with advanced analytics. Regulatory momentum and technological maturation have lowered barriers to adoption, while evolving supply chain practices in response to trade policies have fostered more resilient procurement models. Segmentation analysis highlights the importance of tailoring product and distribution strategies to specific application areas, technology platforms, end user profiles, and channel preferences. Regional insights underscore the need for bespoke entry strategies aligned with local payer systems and infrastructure readiness. Competitive landscapes are characterized by innovation alliances, M&A activity, and a shift toward value propositions that extend beyond contrast performance alone. Together, these factors form a cohesive narrative that guides stakeholders toward informed decision making and strategic planning.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cardiology
      • Left Ventricular Function Analysis
      • Myocardial Perfusion Imaging
    • Oncology
      • Lesion Detection
      • Tumor Characterization
    • Radiology
      • Abdominal Imaging
      • Pediatric Imaging
      • Vascular Imaging
  • Technology Type
    • Liquids
      • Decafluorobutane
      • Perfluorooctyl Bromide
    • Microbubbles
      • Lipid Coated
      • Polymer Coated
      • Protein Coated
    • Nanobubbles
      • Lipid Coated
      • Protein Coated
  • End User
    • Clinics
      • Outpatient Clinics
      • Specialty Clinics
    • Diagnostic Centers
      • Cardiac Care Centers
      • Imaging Centers
    • Hospitals
    • Research Institutes
      • Academic Institutions
      • Contract Research Organizations
  • Distribution Channel
    • Direct Sales
      • Group Purchasing Organizations
      • Hospital Partners
    • Distributor Sales
      • National Distributors
      • Regional Distributors
    • Online Sales
      • Manufacturer Website
      • Third-Party Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Lantheus Medical Imaging, Inc.
  • General Electric Company
  • Sonus Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of targeted microbubbles for molecular imaging and therapeutic applications
5.2. Innovation in biodegradable perfluorocarbon shells enhancing safety and clearance profiles
5.3. Integration of contrast enhanced ultrasound with artificial intelligence driven diagnostics
5.4. Expansion of point of care ultrasound contrast applications in emergency and rural healthcare settings
5.5. Regulatory approvals and revised reimbursement frameworks driving cardiovascular contrast adoption
5.6. Growth of multimodal perfluorocarbon nanoparticles enabling combined ultrasound and MRI imaging
5.7. Advances in liposome encapsulated perfluorocarbon formulations for targeted drug delivery imaging
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Application
8.1. Introduction
8.2. Cardiology
8.2.1. Left Ventricular Function Analysis
8.2.2. Myocardial Perfusion Imaging
8.3. Oncology
8.3.1. Lesion Detection
8.3.2. Tumor Characterization
8.4. Radiology
8.4.1. Abdominal Imaging
8.4.2. Pediatric Imaging
8.4.3. Vascular Imaging
9. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Technology Type
9.1. Introduction
9.2. Liquids
9.2.1. Decafluorobutane
9.2.2. Perfluorooctyl Bromide
9.3. Microbubbles
9.3.1. Lipid Coated
9.3.2. Polymer Coated
9.3.3. Protein Coated
9.4. Nanobubbles
9.4.1. Lipid Coated
9.4.2. Protein Coated
10. Perfluorocarbon-based Ultrasound Contrast Agents Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Outpatient Clinics
10.2.2. Specialty Clinics
10.3. Diagnostic Centers
10.3.1. Cardiac Care Centers
10.3.2. Imaging Centers
10.4. Hospitals
10.5. Research Institutes
10.5.1. Academic Institutions
10.5.2. Contract Research Organizations
11. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Group Purchasing Organizations
11.2.2. Hospital Partners
11.3. Distributor Sales
11.3.1. National Distributors
11.3.2. Regional Distributors
11.4. Online Sales
11.4.1. Manufacturer Website
11.4.2. Third-Party Platforms
12. Americas Perfluorocarbon-based Ultrasound Contrast Agents Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lantheus Medical Imaging, Inc.
15.3.2. General Electric Company
15.3.3. Sonus Pharmaceuticals, Inc.
15.3.4. Daiichi Sankyo Company, Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET: RESEARCHAI
FIGURE 24. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET: RESEARCHSTATISTICS
FIGURE 25. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET: RESEARCHCONTACTS
FIGURE 26. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LEFT VENTRICULAR FUNCTION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LEFT VENTRICULAR FUNCTION ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LESION DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LESION DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TUMOR CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TUMOR CHARACTERIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ABDOMINAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ABDOMINAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PEDIATRIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PEDIATRIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DECAFLUOROBUTANE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DECAFLUOROBUTANE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PERFLUOROOCTYL BROMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PERFLUOROOCTYL BROMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIPID COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIPID COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PROTEIN COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PROTEIN COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIPID COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIPID COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PROTEIN COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY PROTEIN COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY HOSPITAL PARTNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY HOSPITAL PARTNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 187. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 190. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 191. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 194. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 195. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 196. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 197. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 198. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 199. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2018-2024 (USD MILLION)
TABLE 200. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2025-2030 (USD MILLION)
TABLE 201. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2018-2024 (USD MILLION)
TABLE 202. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2025-2030 (USD MILLION)
TABLE 203. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 206. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 207. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 208. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 209. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 210. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 211. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 214. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 215. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
TABLE 216. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2030 (USD MILLION)
TABLE 217. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 218. CANADA PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY MICROBUBBLES, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY NANOBUBBLES, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 250. MEXICO PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL P

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Perfluorocarbon-based Ultrasound Contrast Agents market report include:
  • Lantheus Medical Imaging, Inc.
  • General Electric Company
  • Sonus Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Limited

Related Topics

Related Reports

Perfluorocarbon - Global Strategic Business Report - Product Image

Perfluorocarbon - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Perfluorocarbons Market by Type (Etfe, Fep, Pfa), Application (Coating, Electronics, Lubricants), End Use Industry, Form, Sales Channel - Global Forecast 2025-2030 - Product Image

Perfluorocarbons Market by Type (Etfe, Fep, Pfa), Application (Coating, Electronics, Lubricants), End Use Industry, Form, Sales Channel - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Fluorinated Cooling Fluid for Data Center Market by Fluid Composition (Fluoropolyol Ester, Hydrofluoroether, Perfluorocarbon), Phase Type (Single Phase, Two Phase), End User, Architecture - Global Forecast 2025-2030 - Product Image

Fluorinated Cooling Fluid for Data Center Market by Fluid Composition (Fluoropolyol Ester, Hydrofluoroether, Perfluorocarbon), Phase Type (Single Phase, Two Phase), End User, Architecture - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Perfluorocarbon Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Perfluorocarbon Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Octafluoropropane Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Octafluoropropane Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 81 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.